Trends in Japanese Clinical Trials, 2012-2016

Trends in Japanese Clinical Trials, 2012-2016

15:12, August 7 2017

By GlobalData

Marco Borria, Clinical Trials Analyst, GlobalData, examines key trends in the Japanese clinical trial space

This whitepaper provides a review of clinical trials initiated in Japan between Jan. 1, 2012, and Dec. 31, 2016. The data for this review were derived from the Clinical Trials Database of GlobalData's Pharma Intelligence Center. The aim of this paper is to provide analyses of the main features of these trials, coupled with five-year trends where relevant.

Summary of Contents

3 - Introduction
3 - Report Scope
3 - Methodology
3 - Organizations Mentioned
4 - Japanese Clinical Trial Landscape, 2012-2016
4 - Introduction
4 - Clinical Trials by Sponsor Type and Phase, 2012-2016
6 - Single-Country and Multinational Clinical Trials in Japan
6 - Average Size of Clinical Trials in Japan
8 - Japanese Clinical Trials by Therapy Area
8 - Top Indications for Japanese Clinical Trials
10 - Japanese Clinical Trials by Status
11 - Top Sponsors for Japanese Clinical Trials
13 - Top Drugs Investigated in Japanese Clinical Trials
13 - Summary
15 - About the Authors
15 - Senior Analyst, Clinical Trials Database
15 - Global Director of Databases and Analytics
16 - About the Pharmaceutical Clinical Trials Team
17 - About GlobalData
17 - Contact Us

Download Whitepaper

Trends in Japanese Clinical Trials, 2012-2016
More Whitepapers